Results 241 to 250 of about 3,807,237 (401)

Metabolic engineering of Clostridium acetobutylicum for the industrial production of 1,3-propanediol from glycerol [PDF]

open access: green, 2005
María González-Pajuelo   +5 more
openalex   +1 more source

Increasing galactose consumption by Saccharomyces cerevisiae through metabolic engineering of the GAL gene regulatory network [PDF]

open access: yes, 2000
A Baudin   +29 more
core   +2 more sources

Relationship of cognitive decline with glucocerebrosidase activity and amyloid‐beta 42 in DLB and PD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Abstract Objective Dementia with Lewy bodies (DLB) and Parkinson's disease (PD) share clinical, pathological, and genetic risk factors, including GBA1 and APOEε4 mutations. Biomarkers associated with the pathways of these mutations, such as glucocerebrosidase enzyme (GCase) activity and amyloid‐beta 42 (Aβ42) levels, may hold potential as predictive ...
Maria Camila Gonzalez   +15 more
wiley   +1 more source

Metabolic engineering of lactic acid bacteria, the combined approach: kinetic modelling, metabolic control and experimental analysis The GenBank accession number for the sequence reported in this paper is AY046926.

open access: bronze, 2002
Marcel H. N. Hoefnagel   +8 more
openalex   +1 more source

Metabolic Engineering, Medicinal Resources [PDF]

open access: yes, 2008
El-Halawany Ali Mahmoud   +4 more
core   +1 more source

Dual‐Phase C‐11 PiB PET Images for Detecting Tau Pathology in Cerebral Amyloid Angiopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cerebral amyloid angiopathy (CAA) is a major cause of lobar intracerebral hemorrhage and cognitive dysfunction in the elderly, and frequently coexists with Alzheimer's disease and tau pathology. Dual‐phase 11C‐PiB PET detects amyloid deposition and cerebral perfusion changes and may have diagnostic value for identifying tau in CAA ...
Meng‐Ting Chiang   +4 more
wiley   +1 more source

System metabolic engineering modification of Saccharomyces cerevisiae to increase SAM production. [PDF]

open access: yesBioresour Bioprocess
Tan L   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy